Platelet function testing: auditing local practice and broader implications.

Platelet function testing is widely used to evaluate patients with bleeding disorders or those on antiplatelet therapy. Despite its prevalence, practice lacks standardization, and experts disagree on its optimal use. Prior research has shown that light transmission aggregometry (LTA) and PFA-100 closure times are commonly used diagnostic tools. However, no prior work had resolved how specific procedural variations affect diagnostic accuracy. This gap motivated a local audit to assess whether adjustments in platelet count using autologous plasma or tube selection for PFA-100 testing influence results. That uncertainty drove the need to evaluate local practices against CLSI guidelines. No prior work had resolved whether these procedural choices could lead to misdiagnosis of platelet dysfunction. This audit aimed to clarify these uncertainties by comparing local practices to standardized recommendations.

The study aimed to audit local laboratory practices for platelet function testing in light of recent reports and CLSI guidelines. It focused on two key areas: the use of autologous platelet-poor plasma (PPP) in LTA testing and the impact of blood collection tubes on PFA-100 closure times. These practices are not universally standardized, and their influence on diagnostic outcomes remains unclear. The researchers sought to determine whether these procedural choices could lead to inaccurate conclusions about platelet dysfunction. This audit aimed to identify potential misinterpretations of test results due to procedural variability. The motivation stemmed from the lack of consensus among experts regarding optimal testing protocols. No prior work had resolved how these variations affect diagnostic reliability in real-world settings.

The study evaluated current laboratory practices for platelet function testing using two approaches. First, it assessed the impact of platelet count adjustments using autologous PPP in LTA testing. Second, it examined how different blood collection tubes affected PFA-100 closure times. These assessments were based on local audit data and compared to CLSI guidelines. The researchers used a retrospective review of test procedures and outcomes. They focused on agonists like collagen, ADP, and epinephrine in LTA testing. For PFA-100 testing, they analyzed closure times across different tube types. The goal was to determine whether these procedural choices altered diagnostic outcomes. No prior work had resolved how these variables influence test accuracy in real-world settings.

Using autologous PPP in LTA testing significantly reduced detectable platelet function with several agonists. This effect was most pronounced with collagen, ADP, and epinephrine. These reductions could lead to misclassification of platelet dysfunction severity. For PFA-100 testing, different blood collection tubes produced slightly different closure times. These variations could influence whether a patient's results are labeled as normal or abnormal. The study found that PPP adjustments may not align with CLSI recommendations. The observed effects suggest that procedural choices can alter diagnostic outcomes. These findings indicate a need for local validation of testing protocols. No prior work had shown how these procedural differences could affect clinical conclusions.

The audit found that using autologous PPP in LTA testing may reduce detectable platelet function, potentially leading to misdiagnosis. The authors suggest that laboratories should validate this practice if used locally. For PFA-100 testing, tube selection can influence closure times, and local validation of reference ranges is recommended. These findings suggest that procedural choices may affect diagnostic accuracy. The authors propose that laboratories should review their current practices in light of these results. No prior work had shown how these variations could impact clinical outcomes. These conclusions align with the observed effects in the audit. The authors suggest that standardization efforts should include local validation of testing protocols.